RESPIRATORY SYNCYTIAL VIRUS VIRCLIA® IGG MONOTEST - INVIMA Registration 8cca771adc51c5e06202ed7fee027750
Access comprehensive regulatory information for RESPIRATORY SYNCYTIAL VIRUS VIRCLIA® IGG MONOTEST (RESPIRATORY SYNCYTIAL VIRUS VIRCLIA® IGG MONOTEST) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID 8cca771adc51c5e06202ed7fee027750 and manufactured by ANNAR DIAGNOSTICA IMPORT S.A.S..
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
INMUNOENSAYO QUIMIOLUMINISCENTE INDIRECTO (CLIA) PARA DETERMINAR ANTICUERPOS _x000D_ IGG ESPECÍFICOS FRENTE A VIRUS SINCITIAL RESPIRATORIO EN SUERO/PLASMA HUMANO. _x000D_ ESTE PRODUCTO ES UN ANÁLISIS CUALITATIVO Y AUTOMATIZADO, DESTINADO PARA SER USADO _x000D_ COMO AYUDA AL DIAGNÓSTICO.
INDIRECT CHEMILUMINESCENT IMMUNOASSAY (CLIA) TO DETERMINE ANTIBODIES _x000D_ IGG SPECIFIC AGAINST RESPIRATORY SYNCYTIAL VIRUS IN HUMAN SERUM/PLASMA. _x000D_ THIS PRODUCT IS A QUALITATIVE AND AUTOMATED ANALYSIS, INTENDED TO BE USED _x000D_ AS AN AID TO DIAGNOSIS.